期刊文献+

儿童变应性鼻炎免疫治疗的适应证及安全性 被引量:10

原文传递
导出
摘要 在变应性鼻炎(AR)治疗体系中,药物治疗的应用范围最为广泛,其目的是控制临床症状,但对致病的免疫机制无显著作用。变应原特异性免疫治疗是目前惟一可能通过免疫调节机制改变AR自然进程的治疗方式,可调节患者全身免疫机能,由此阻断或逆转疾病进程,取得药物治疗无法产生的整体疗效,包括:①减轻变应原暴露引发的症状:
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第1期17-18,共2页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
  • 相关文献

参考文献14

  • 1Alvarez-Cuesta E,Bousquet J,Canonica GW,et al.Standards for practical allergen-specific immunotherapy.Allergy,2006,61Suppl 82:1-20.
  • 2Bousquet J,van Cauwenberge P,Bachert C,et al.Allergic rhinitis and its impact on asthma.J Allergy Clin Immunol,2001,108 (5 Suppl):S147-334.
  • 3Jacobsen L,Niggemann B,Dreborg S,et al.Specific immunotherapy has long-term preventive effect of srasonal and perennial asthma:10-year follow-up on the PAT study.Allergy,2007,62:943-948.
  • 4Golden DB,Kagey-Sobotka A,Norman PS,et al.Outcomes of allergy to insect stings in children,with and without venom immunotherapy.N Engl J Med,2004,351:668-674.
  • 5程雷,李华斌.世界变态反应组织舌下免疫治疗意见书(2009)解读[J].中华耳鼻咽喉头颈外科杂志,2011,46(1):80-83. 被引量:31
  • 6张罗,韩德民.变应性鼻炎的变应原特异性皮下免疫治疗[J].中华耳鼻咽喉头颈外科杂志,2007,42(9):711-716. 被引量:26
  • 7Zhang L,Wang C,Han D,et al.Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic thinitis.Int Arch Allergy Immunol,2009,148:161-169.
  • 8Pfaar O,Leitzbach S,Hormann K,et al.Cluster protocols in SCIT:enough evidence for practical use? Curr Opinion in Allergy and Clin Immunol,2010,10:188-193.
  • 9Bernstein DI,Wanner M,Borish L,et al.Twelve-year survey of fatal reactions to allergen injections and skin testing:1990-2001.J Allergy Clin Immunol,2004,113:1129-1136.
  • 10Lockey RF,Benedict LM,Turkeltaub PC,et al.Fatalities from immunotherapy (IT) and skin testing (ST).J Allergy Clin Immunol,1987,79:660-677.

二级参考文献40

  • 1顾之燕.呼吸道变应性炎症性疾病特异性舌下免疫治疗[J].中华耳鼻咽喉头颈外科杂志,2006,41(7):553-556. 被引量:9
  • 2Bousquet J,Khaltaev N,Cruz AA,et al.Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization,GA2 LEN and AllerGen).Allergy,2008,63 Suppl 86:8-160.
  • 3Canonica GW,Bousquet J,Casale T,et al.Sub-lingual immunotherapy:World Allergy Organization Position Paper 2009.Allergy,2009,64 Suppl 91:1-59.
  • 4Harvey SM, Laurie S, Hilton K, et al. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Ann Allergy Asthma Immunol, 2004, 92: 414-419.
  • 5Hejjaoui A, Dhivert H, Michel FB, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol, 1990, 85 : 473-479.
  • 6Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol, 2001, 108: 871-873.
  • 7Norman PS. Immunotherapy: past and present. J Allergy Clin Immunol, 1998, 102: 1-10.
  • 8Cohen SG, Frankland AW, Dworetzky M. Noon and Freeman on prophylactic inoculation against hay fever. J Allergy Clin Immunol, 2003, 111: 1142-1150.
  • 9Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol, 2006, 97: 126-137.
  • 10Ewan PW, Ackroyd JF. Desensitising vaccines: an allergist's view. Br Med J (Clin Res Ed) , 1986, 293(6555) : 1169-1170.

共引文献141

同被引文献146

引证文献10

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部